NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

Novozymes has successfully implemented NSF TraQtion for managing raw material quality and continuously improve compliance for the production of enzymes and proteins across several industries

NSF, a leading global public health and safety organization, is pleased to announce that Novozymes, a leader in biosolutions, has become the world’s first company to implement NSF TraQtion software for managing the quality and compliance of raw materials used in the production of enzymes and proteins serving multiple industries.

NSF TraQtion is a cloud-based quality and compliance software that provides organizations with a comprehensive platform to proactively manage their supply chain, sites, and product quality. NSF TraQtion was initially developed to help customers maintain a higher level of food safety and quality compliance. Its implementation by Novozymes demonstrates the versatility of the software across diverse industries, offering timely and insightful information for making informed decisions.

As an industry pioneer in risk management and mitigation solutions, NSF has a proven track record of ensuring product safety, quality, and compliance across various sectors, including food and health science. In today’s increasingly complex supply chains, risks stemming from globalization, extreme weather events, geopolitical influences, and persistent raw material inflation highlight the need for more robust supply chain management solutions.

Matthew Allen, Senior Director, Food & Sustainability Advisory Solutions at NSF……

“We are delighted to have Novozymes as a client utilizing NSF TraQtion. This achievement showcases the versatility and effectiveness of NSF TraQtion digital solutions across diverse industries. With our extensive expertise and deep understanding of global supply chain dynamics, we are confident in our ability to support Novozymes in enhancing their raw material management process.”

Novozymes is also exploring applications of NSF TraQtion within dietary supplements and health sciences in the future, marking the start of NSF TraQtion’s expansion into these sectors.

NSF TraQtion software offers comprehensive data management and business intelligence capabilities. It combines decades of industry expertise with real-time digital insights in a trusted, cloud-based solution that provides businesses with the assurance they need to confidently manage complex and critical data – including supplier compliance, regulatory requirements, and environmental reporting.

“The adoption of NSF TraQtion by Novozymes underscores NSF’s commitment to delivering cutting-edge solutions to address emerging challenges across industries. By harnessing advanced technologies and industry expertise, NSF TraQtion empowers organizations to proactively manage risk, ensure compliance and product quality, and fortify the overall resilience of their supply chains in a single, secure platform,” stated David Lonza, Vice President, Health Sciences, NSF.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”